Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% ...

Life sciences company Element Biosciences sued Illumina on Monday in separate cases in federal courts in California and ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...

Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD device.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Obtaining an accurate diagnosis is a crucial first step in kidney cancer care, according to Dr. Shuanzeng “Sam” Wei of Fox ...

Molecular testing helps distinguish kidney cancer subtypes, ensuring patients get accurate diagnoses and treatment plans, ...

SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its ...

PacBio enters the high-throughput carrier screening market with a standalone HiFi sequencing assay for challenging genes.

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple ...

The T7+ integrates MGI's proprietary DNBSEQ™ technology with next-generation fluidics, optics, and bioinformatics, creating a platform that is faster, smarter, and more versatile than ever before. The ...

The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.